Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 03-2025 | 01-2025 | 12-2024 | 10-2024 | 09-2024 | |
| Operating Expenses | 49,708 | 42,940 | 0 | 45,811 | 43,480 |
| Operating Income | -49,708 | -42,940 | N/A | -45,811 | -43,480 |
| Interest Expense | 2,937 | 2,842 | 0 | 0 | 0 |
| Other Income | 5,056 | 1,520 | 0 | 3,543 | 4,396 |
| Pre-tax Income | -47,589 | -44,262 | 0 | -42,268 | -39,084 |
| Income Tax | 4,247 | 4,247 | N/A | N/A | N/A |
| Net Income Continuous | -51,836 | -48,509 | N/A | -42,268 | -39,084 |
| Net Income | $-51,836 | $-48,509 | $N/A | $-42,268 | $-39,084 |
| EPS Basic Total Ops | -0.98 | -0.92 | N/A | -0.91 | -0.84 |
| EPS Basic Continuous Ops | -0.98 | -0.92 | N/A | -0.91 | -0.84 |
| EPS Diluted Total Ops | -0.98 | -0.92 | N/A | -0.91 | -0.84 |
| EPS Diluted Continuous Ops | -0.98 | -0.92 | N/A | -0.91 | -0.84 |
| EPS Diluted Before Non-Recurring Items | -0.99 | N/A | -0.92 | N/A | -0.91 |
| EBITDA(a) | $-49,017 | $-42,249 | $N/A | $-45,126 | $-43,480 |